Radioimmunotherapy of acquired immunodeficiency syndrome (AIDS) associated lymphoma

Cancer Biotherapy and Radiopharmaceuticals

Volumn 14, Issue 3, 1999, Pages 167-176

  O'Donnell, Robert T ^a,b,c   Leigh, Bryan R ^a   Christensen, Scott D ^a,b   Goldstein, Desireé S ^a   Kukis, David L ^a   Shen, Sui ^a   Yuan, Aina ^a   DeNardo, Diane A ^a   Kroger, Linda A ^a   DeNardo, Gerald L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

^c NONE   (United States)

Author keywords

Acquired immunodeficiency syndrome; Lym 1; Non Hodgkin's lymphoma; Radioimmunotherapy; Yttrium 90

Indexed keywords

INDIUM; MONOCLONAL ANTIBODY LYM 1; UNCLASSIFIED DRUG; YTTRIUM 90;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY RESPONSE; ARTICLE; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DRUG ACCUMULATION; DRUG TARGETING; HUMAN; MALE; NONHODGKIN LYMPHOMA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; RADIOSENSITIVITY; TUMOR REGRESSION;

EID: 0032998005     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.1999.14.167     Document Type: Article

References (30)

1. Revision of the case definition of acquired immunodeficiency syndrome for national reporting - United States. Morb Mortal Wkly Rep 1985;34:313.
2. Wang CY, Snow JL, Su WP. Lymphoma associated with human immunodeficiency virus infection. Mayo Clin Proc 1995;70:665.
3. Broder S. Factors in the development of AIDS-related lymphomas. Leukemia 1992;6:6.
4. Safai B, Diaz B, Schwarte J. Malignant neoplasms associated with human immunodeficiency virus infection [published erratum appears in CA Cancer J Clin 1992 Jul-Aug;42(4):254]. CA Cancer J Clin 1992;42:74.
5. Levine AM, Wernz JC, Kaplan L, Rodman N, Cohen P, Metroka C, Bennett JM, Rarick MU, Walsh C, Kahn J. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA 1991;266:84.
6. Biggar RJ, Rabkin CS. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr Opin Oncol 1992;4:883.
7. Peters BS, Beck EJ, Coleman DG, Wadsworth MJ, McGuinness O, Harris JR, Pinching AJ. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. Br Med J 1991;302:203.
8. Epstein AL, Marder RJ, Winter JN, Stathopoulos E, Chen FM, Parker JW, Taylor CR. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human-B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res 1987;47:830.
9. 131I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. J Clin Oncol 1998;16:3246.
10. 131I-Lym-1 antibody. Cancer Biother Radiopharm 1998;13:239.
11. Lamborn KR, DeNardo GL, DeNardo SJ, Goldstein DS, Shen S, Larkin EC, Kroger LA. Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies. Clin Cancer Res 1997;3:1253.
12. DeNardo GL, DeNardo SJ, Meares CF, Kukis DL, Diril H, McCall MJ, Adams GP, Mausner LF, Moody DC, Deshpande SV. Pharmacokinetics of copper-67 conjugated Lym-1, a potential therapeutic radioimmunoconjugate, in mice and patients with lymphoma. Antibody Immunoconj Radiophar 1991;4:777.
13. DeNardo GL, Kukis DL, Shen S, DeNardo DA, Meares CF, DeNardo SJ. Copper-67 versus iodine-131 labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma. Clin Cancer Res, In Press, 1999.
14. DeNardo SJ, Kramer EL, O'Donnell RT, Richman CM, Salako QA, Shen S, Noz M, Glenn SD, Ceriani RL, DeNardo GL. Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. J Nucl Med 199738:1180.
15. Moi MK, DeNardo SJ, Meares CF. Stable bifunctional chelates of metals used in radiotherapy. Cancer Res 1990;50:789.
16. Rose LM, Gunasekera AH, DeNardo SJ, DeNardo GL, Meares CF. Lymphoma-selective antibody Lym-1 recognizes a discontinuous epitope on the light chain of HLA-DR10. Cancer Immunol Immunother 1996;43: 26.
17. DeNardo GL, Mills SL, Kukis DL, Anderson V, DeNardo SJ. Review of a four-year experience iodinating monoclonal antibodies with therapeutic amounts of I-131. Antibody Immunoconj Radiophar 1995;8:1.
18. DeNardo GL, Mirick GR, Kroger LA, O'Donnell RT, Meares CF, DeNardo SJ. Antibody responses to macrocycles in lymphoma. J Nucl Med 1996;37:451.
19. Rubin P, Casarett GW. Medical Radiation Biology 8 Concepts of Clinical Radiation Pathology. Dalrymple GV, Gaulden ME, Kollmorgen GM et al (eds). W. B. Sanders Company, Philadelphia, 1973, 185.
20. Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko GM, Fisher LD, Porter B, et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;329:1219.
21. Shen S, DeNardo GL, DeNardo SJ, Yuan A, DeNardo DA, Lamborn KR. Reproducibility of operator processing for radiation dosimetry. Nucl Med Biol 1997;24:77.
22. Loevinger R, Berman M. A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MIRD Pamphlet No. 1. New York: Society of Nuclear Medicine; 1976; 1p.
23. 131I-Lym-1. Cancer Res 1990;50:1014.
24. Eyre HJ, Farver ML. Hodgkin's Disease and Non-Hodgkin's Lymphomas. In:Textbook of Clinical Oncology Holleb AI, Fink DJ, Murphy GP(eds) 1, American Cancer Society, Atlanta, GA, 1991, 377.
25. DeNardo SJ, Gumerlock PH, Winthrop MD, Mack PC, Chi SG, Lamborn KR, Shen S, Miers LA, deVere White RW, DeNardo GL. Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression. Cancer Res 1995;55:5837.
26. Meyn RE. Apoptosis and response to radiation: implications for radiation therapy. Oncology (Huntingt) 1997;11:349.
27. Macklis RM, Beresford BA, Palayoor S, Sweeney S, Humm JL. Cell cycle alterations, apoptosis, and response to low-dose-rate radioimmunotherapy in lymphoma cells. Int J Radiat Oncol Biol Phys 1993;27: 643.
28. DeNardo GL, Kroger LA, DeNardo SJ, Miers LA, Salako Q, Kukis DL, Fand I, Shen S, Renn O, Meares CF. Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer 1994;73:1012.
29. Lim S-M, DeNardo GL, DeNardo DA, O'Donnell RT, Shen S, Yuan A, DeNardo SJ. Prediction of myelotoxicity using semi-quantitative marrow image scores. J Nucl Med 1997;38:1749.
30. DeNardo GL, Kroger LA, Mirick GR, Lamborn KR, DeNardo SJ. Analysis of antiglobulin (HAMA) response in a group of patients with B-lymphocyte malignancies treated with 131I-Lym-1. Int J Biol Markers 1995;10:67.